Publication | Closed Access

Effects of Histamine 2-receptor Antagonists and Proton Pump Inhibitors on the Pharmacokinetics of Gefitinib in Patients With Non–small-cell Lung Cancer

Non–small-cell Lung CancerOncologyMedicineMetronomic TherapyProton Pump InhibitorsPharmacotherapyCancer TreatmentPharmacologyLung CancerHistamine 2-Receptor Antagonists